1887

Abstract

The hepatitis C virus (HCV) non-structural (NS) 3/4A protein complex inhibits the retinoic acid inducible gene I (RIG-I) pathway by proteolytically cleaving mitochondria-associated CARD-containing adaptor protein Cardif, and this leads to reduced production of beta interferon (IFN-). This study examined the expression of CCL5 (regulated upon activation, normal T-cell expressed and secreted, or RANTES), CXCL8 (interleukin 8) and CXCL10 (IFN--activated protein 10, or IP-10) chemokine genes in osteosarcoma cell lines that inducibly expressed NS3/4A, NS4B, core-E1-E2-p7 and the entire HCV polyprotein. Sendai virus (SeV)-induced production of IFN-, CCL5, CXCL8 and CXCL10 was downregulated by the NS3/4A protein complex and by the full-length HCV polyprotein. Expression of NS3/4A and the HCV polyprotein reduced the binding of interferon regulatory factors (IRFs) 1 and 3 and, to a lesser extent, nuclear factor (NF)-B (p65/p50) to their respective binding elements on the CXCL10 promoter during SeV infection. Furthermore, binding of IRF1 and IRF3 to the interferon-stimulated response element-like element, and of c-Jun and phosphorylated c-Jun to the activator protein 1 element of the CXCL8 promoter, was reduced when NS3/4A and the HCV polyprotein were expressed. In cell lines expressing NS3/4A and the HCV polyprotein, the subcellular localization of mitochondria was changed, and this was kinetically associated with the partial degradation of endogenous Cardif. These results indicate that NS3/4A alone or as part of the HCV polyprotein disturbs the expression of IRF1- and IRF3-regulated genes, as well as affecting mitogen-activated protein kinase kinase- and NF-B-regulated genes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83316-0
2008-02-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/2/432.html?itemId=/content/journal/jgv/10.1099/vir.0.83316-0&mimeType=html&fmt=ahah

References

  1. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. ( 2001; ). Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738.[CrossRef]
    [Google Scholar]
  2. Barba, G., Harper, F., Harada, T., Kohara, M., Goulinet, S., Matsuura, Y., Eder, G., Schaff, Z., Chapman, M. J. & other authors ( 1997; ). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 94, 1200–1205.[CrossRef]
    [Google Scholar]
  3. Bradford, M. M. ( 1976; ). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.[CrossRef]
    [Google Scholar]
  4. Casola, A., Garofalo, R. P., Jamaluddin, M., Vlahopoulos, S. & Brasier, A. R. ( 2000; ). Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J Immunol 164, 5944–5951.[CrossRef]
    [Google Scholar]
  5. Cheng, G., Zhong, J. & Chisari, F. V. ( 2006; ). Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 103, 8499–8504.[CrossRef]
    [Google Scholar]
  6. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. ( 1979; ). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299.[CrossRef]
    [Google Scholar]
  7. Ciccaglione, A. R., Stellacci, E., Marcantonio, C., Muto, V., Equestre, M., Marsili, G., Rapicetta, M. & Battistini, A. ( 2007; ). Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J Virol 81, 202–214.[CrossRef]
    [Google Scholar]
  8. Ferreon, J. C., Ferreon, A. C., Li, K. & Lemon, S. M. ( 2005; ). Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 280, 20483–20492.[CrossRef]
    [Google Scholar]
  9. Foy, E., Li, K., Wang, C., Sumpter, R., Jr, Ikeda, M., Lemon, S. M. & Gale, M., Jr ( 2003; ). Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145–1148.[CrossRef]
    [Google Scholar]
  10. Foy, E., Li, K., Sumpter, R., Jr, Loo, Y. M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T. & other authors ( 2005; ). Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 102, 2986–2991.[CrossRef]
    [Google Scholar]
  11. Gack, M. U., Shin, Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z. & other authors ( 2007; ). TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916–920.[CrossRef]
    [Google Scholar]
  12. Gale, M., Jr & Foy, E. M. ( 2005; ). Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939–945.[CrossRef]
    [Google Scholar]
  13. Genin, P., Algarte, M., Roof, P., Lin, R. & Hiscott, J. ( 2000; ). Regulation of RANTES chemokine gene expression requires cooperativity between NF-κB and IFN-regulatory factor transcription factors. J Immunol 164, 5352–5361.[CrossRef]
    [Google Scholar]
  14. Glisin, V., Crkvenjakov, R. & Byus, C. ( 1974; ). Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13, 2633–2637.[CrossRef]
    [Google Scholar]
  15. Green, J., Khabar, K. S., Koo, B. C., Williams, B. R. & Polyak, S. J. ( 2006; ). Stability of CXCL-8 and related AU-rich mRNAs in the context of hepatitis C virus replication in vitro. J Infect Dis 193, 802–811.[CrossRef]
    [Google Scholar]
  16. Griffin, S. D., Beales, L. P., Clarke, D. S., Worsfold, O., Evans, S. D., Jaeger, J., Harris, M. P. & Rowlands, D. J. ( 2003; ). The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 535, 34–38.[CrossRef]
    [Google Scholar]
  17. Hoffmann, E., Dittrich-Breiholz, O., Holtmann, H. & Kracht, M. ( 2002; ). Multiple control of interleukin-8 gene expression. J Leukoc Biol 72, 847–855.
    [Google Scholar]
  18. Hugle, T., Fehrmann, F., Bieck, E., Kohara, M., Krausslich, H. G., Rice, C. M., Blum, H. E. & Moradpour, D. ( 2001; ). The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology 284, 70–81.[CrossRef]
    [Google Scholar]
  19. Kato, N., Yoshida, H., Kioko Ono-Nita, S., Kato, J., Goto, T., Otsuka, M., Lan, K., Matsushima, K., Shiratori, Y. & Omata, M. ( 2000; ). Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32, 405–412.[CrossRef]
    [Google Scholar]
  20. Kaukinen, P., Sillanpaa, M., Kotenko, S., Lin, R., Hiscott, J., Melen, K. & Julkunen, I. ( 2006; ). Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J 3, 66 [CrossRef]
    [Google Scholar]
  21. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O. & Akira, S. ( 2005; ). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6, 981–988.[CrossRef]
    [Google Scholar]
  22. Koike, K. & Miyoshi, H. ( 2006; ). Oxidative stress and hepatitis C viral infection. Hepatol Res 34, 65–73
  23. Koo, B. C., McPoland, P., Wagoner, J. P., Kane, O. J., Lohmann, V. & Polyak, S. J. ( 2006; ). Relationships between hepatitis C virus replication and CXCL-8 production in vitro. J Virol 80, 7885–7893.[CrossRef]
    [Google Scholar]
  24. Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C., Ikeda, M., Ray, S. C., Gale, M., Jr & Lemon, S. M. ( 2005a; ). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102, 2992–2997.[CrossRef]
    [Google Scholar]
  25. Li, X. D., Sun, L., Seth, R. B., Pineda, G. & Chen, Z. J. ( 2005b; ). Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102, 17717–17722.[CrossRef]
    [Google Scholar]
  26. Lin, R., Lacoste, J., Nakhaei, P., Sun, Q., Yang, L., Paz, S., Wilkinson, P., Julkunen, I., Vitour, D. & other authors ( 2006a; ). Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKϵ molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80, 6072–6083.[CrossRef]
    [Google Scholar]
  27. Lin, W., Kim, S. S., Yeung, E., Kamegaya, Y., Blackard, J. T., Kim, K. A., Holtzman, M. J. & Chung, R. T. ( 2006b; ). Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 80, 9226–9235.[CrossRef]
    [Google Scholar]
  28. Lindenbach, B. D. & Rice, C. M. ( 2005; ). Unravelling hepatitis C virus replication from genome to function. Nature 436, 933–938.[CrossRef]
    [Google Scholar]
  29. Loo, Y. M., Owen, D. M., Li, K., Erickson, A. K., Johnson, C. L., Fish, P. M., Carney, D. S., Wang, T., Ishida, H. & other authors ( 2006; ). Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103, 6001–6006.[CrossRef]
    [Google Scholar]
  30. Matikainen, S., Ronni, T., Hurme, M., Pine, R. & Julkunen, I. ( 1996; ). Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88, 114–123.
    [Google Scholar]
  31. Matikainen, S., Siren, J., Tissari, J., Veckman, V., Pirhonen, J., Severa, M., Sun, Q., Lin, R., Meri, S. & other authors ( 2006; ). Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 80, 3515–3522.[CrossRef]
    [Google Scholar]
  32. Melchjorsen, J., Jensen, S. B., Malmgaard, L., Rasmussen, S. B., Weber, F., Bowie, A. G., Matikainen, S. & Paludan, S. R. ( 2005; ). Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79, 12944–12951.[CrossRef]
    [Google Scholar]
  33. Melen, K., Fagerlund, R., Nyqvist, M., Keskinen, P. & Julkunen, I. ( 2004; ). Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs. J Med Virol 73, 536–547.[CrossRef]
    [Google Scholar]
  34. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R. & Tschopp, J. ( 2005; ). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.[CrossRef]
    [Google Scholar]
  35. Miettinen, M., Matikainen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M. & Julkunen, I. ( 1998; ). Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun 66, 6058–6062.
    [Google Scholar]
  36. Moradpour, D., Kary, P., Rice, C. M. & Blum, H. E. ( 1998; ). Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. Hepatology 28, 192–201.
    [Google Scholar]
  37. Moradpour, D., Brass, V., Gosert, R., Wolk, B. & Blum, H. E. ( 2002; ). Hepatitis C: molecular virology and antiviral targets. Trends Mol Med 8, 476–482.[CrossRef]
    [Google Scholar]
  38. Mukaida, N., Okamoto, S., Ishikawa, Y. & Matsushima, K. ( 1994; ). Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56, 554–558.
    [Google Scholar]
  39. Nomura-Takigawa, Y., Nagano-Fujii, M., Deng, L., Kitazawa, S., Ishido, S., Sada, K. & Hotta, H. ( 2006; ). Non-structural protein 4A of hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis. J Gen Virol 87, 1935–1945.[CrossRef]
    [Google Scholar]
  40. Ohmori, Y. & Hamilton, T. A. ( 1993; ). Cooperative interaction between interferon (IFN) stimulus response element and κB sequence motifs controls IFNγ- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J Biol Chem 268, 6677–6688.
    [Google Scholar]
  41. Osterlund, P., Veckman, V., Siren, J., Klucher, K. M., Hiscott, J., Matikainen, S. & Julkunen, I. ( 2005; ). Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 79, 9608–9617.[CrossRef]
    [Google Scholar]
  42. Otsuka, M., Kato, N., Moriyama, M., Taniguchi, H., Wang, Y., Dharel, N., Kawabe, T. & Omata, M. ( 2005; ). Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41, 1004–1012.[CrossRef]
    [Google Scholar]
  43. Piccoli, C., Scrima, R., D'Aprile, A., Ripoli, M., Lecce, L., Boffoli, D. & Capitanio, N. ( 2006; ). Mitochondrial dysfunction in hepatitis C virus infection. Biochim Biophys Acta 1757, 1429–1437.
  44. Ray, R. B., Steele, R., Basu, A., Meyer, K., Majumder, M., Ghosh, A. K. & Ray, R. ( 2002; ). Distinct functional role of hepatitis C virus core protein on NF-κB regulation is linked to genomic variation. Virus Res 87, 21–29.[CrossRef]
    [Google Scholar]
  45. Schwer, B., Ren, S., Pietschmann, T., Kartenbeck, J., Kaehlcke, K., Bartenschlager, R., Yen, T. S. & Ott, M. ( 2004; ). Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol 78, 7958–7968.[CrossRef]
    [Google Scholar]
  46. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. ( 2005; ). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122, 669–682.[CrossRef]
    [Google Scholar]
  47. Siren, J., Pirhonen, J., Julkunen, I. & Matikainen, S. ( 2005; ). IFN-α regulates TLR-dependent gene expression of IFN-α, IFN-β, IL-28, and IL-29. J Immunol 174, 1932–1937.[CrossRef]
    [Google Scholar]
  48. Veckman, V., Osterlund, P., Fagerlund, R., Melen, K., Matikainen, S. & Julkunen, I. ( 2006; ). TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 345, 96–104.[CrossRef]
    [Google Scholar]
  49. Wagoner, J., Austin, M., Green, J., Imaizumi, T., Casola, A., Brasier, A., Khabar, K. S., Wakita, T., Gale, M., Jr & Polyak, S. J. ( 2007; ). Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol 81, 309–318.[CrossRef]
    [Google Scholar]
  50. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M. & Maniatis, T. ( 1998; ). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol Cell 1, 507–518.[CrossRef]
    [Google Scholar]
  51. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C. Y., Shyu, A. B., Muller, M., Gaestel, M., Resch, K. & Holtmann, H. ( 1999; ). The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 18, 4969–4980.[CrossRef]
    [Google Scholar]
  52. Winzen, R., Gowrishankar, G., Bollig, F., Redich, N., Resch, K. & Holtmann, H. ( 2004; ). Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 24, 4835–4847.[CrossRef]
    [Google Scholar]
  53. Wolk, B., Sansonno, D., Krausslich, H. G., Dammacco, F., Rice, C. M., Blum, H. E. & Moradpour, D. ( 2000; ). Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol 74, 2293–2304.[CrossRef]
    [Google Scholar]
  54. Xu, L. G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z. & Shu, H. B. ( 2005; ). VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol Cell 19, 727–740.[CrossRef]
    [Google Scholar]
  55. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K. & Akira, S. ( 2002; ). Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J Immunol 169, 6668–6672.[CrossRef]
    [Google Scholar]
  56. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S. & Fujita, T. ( 2004; ). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730–737.[CrossRef]
    [Google Scholar]
  57. Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D. W., Hiscott, J. & Lin, R. ( 2007; ). The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways. Nat Immunol 8, 592–600.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83316-0
Loading
/content/journal/jgv/10.1099/vir.0.83316-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error